ALPP yields 285714.29% · PFE yields 6.13%● Live data
📍 ALPP pulled ahead of the other in Year 1
Combined, ALPP + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALPP + PFE for your $10,000?
Alpine 4 Holdings, Inc. a technology holding company, provides electronic contract manufacturing solutions in the United States. The company also offers automotive technologies, including 6th Sense Auto, a connected car technology that provides various advantages to management, sales, finance, and service departments in the automotive dealership industry to enhance productivity, profitability, and customer retention; and BrakeActive, a safety device that enhances vehicle's third brake light's ability to reduce or prevent a rear-end collision. In addition, it designs, fabricates, and installs dust collectors, commercial ductwork, kitchen hoods, industrial ventilation systems, machine guards, architectural work, water furnaces, and other products, as well as offers specialized spiral ductwork. Further, the company provides logistics services for various industries, such as medical, consumer electronics, energy, and disaster relief; contract manufacturing services for dietary and nutritional supplements; international contracting, fabricator, and project management services; and geospatial and 3D data services for various industries, including construction, oil/gas, mining, and quarries. It also manufacturers and sells electronic components; and designs, manufactures, and distributes commercial LED lighting and electronics, such as televisions, mounting solutions, projectors and screens, audio equipment, digital signage, mobile audio and video systems, and various wire and connecting products. The company was formerly known as Alpine 4 Technologies, Ltd. and changed its name to Alpine 4 Holdings, Inc. in March 2021. Alpine 4 Holdings, Inc. was incorporated in 2014 and is based in Phoenix, Arizona.
Full ALPP Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.